
CADENCE Phase 2 Data Support WINREVAIR™ in CpcPH-HFpEF
Merck Reports Positive Phase 2 CADENCE Results for WINREVAIR in CpcPH-HFpEF, Supporting Advancement to Phase 3 Merck has announced encouraging results from its Phase 2 CADENCE clinical trial evaluating WINREVAIR™…












